798 results on '"Moore, A. D."'
Search Results
2. Novartis to update leukemia pill data
3. Glaxo pulls Lotronex from U.S. after losing dispute with FDA
4. Vaccination program may form model for getting medicines to poor countries
5. Bayer and Avigen collaborate on gene therapy
6. Aventis plans to split off its Agro-unit
7. BASF has talked of drug-unit sale to others in sector
8. Aventis posts strong life-science results as charges lead to group profit decline
9. Corn-recall cost could reach hundreds of millions even as some firms benefit
10. Roche works to rebuild its reputation and share price
11. Merger partners Glaxo and SmithKline post strong results for third quarter
12. Vitamin makers still face EU objections
13. Novartis, AstraZeneca shape plans for merger of agribusiness units
14. Glaxo, SmithKline merger hits snags as FTC seeks more data
15. Elan to buy Dura Pharmaceuticals for $1.8 billion
16. France's Sanofi posts 58% profit surge amid shake-up
17. SmithKline's sale of two drugs helps clear way for Glaxo deal
18. Swiss drug firm reports 12% gain in first-half profit
19. Roche finds Alzheimer's gene link
20. Roche Holding 1st-half net quadruples, but shares slip on disappointing sales
21. British panel urges fewer curbs on cloning embryos for research
22. AstraZeneca's net income soars, but sales of Prilosec are down
23. Glaxo Wellcome's profit, sales rebound, boosting confidence in SmithKline deal
24. Biotechnology executives discuss the impact of the genetic revolution
25. Holes in the Net; in drug-cost debate, Europe offers U.S. telling side effect; for EU, drive to control prices has cut access to cancer treatments
26. Swiss giant moves to rev up drug flagship; Novartis shuffles managers in marketing maneuver as new products near
27. Glaxo diabetes drug is dealt setback as SmithKline proceeds with merger
28. French biotech firm Genset taps Pernet to succeed CEO, co-founder Brandys
29. Terms of Aventis-Millennium alliance underscore growing clout of biotechs
30. Roche shares fall on sales warning for drug division
31. Qiagen to acquire Operon Technologies in a bid to catch U.S. genetics rivals
32. BASF hopes U.S. listing will lift stock
33. News about leukemia unexpectedly puts Novartis on the spot
34. Ciba Vision agrees to buy Wesley Jessen
35. Next milestone in human genetics; new DNA map is expected to advance experiments in gene-based medicine
36. Novartis method to track gene changes in plants may help sell altered crops
37. AstraZeneca's new ulcer drug shows some advantage
38. Aventis's new drugs are growing part of firm
39. Novartis, seeking U.S. market share, moves to NYSE
40. Europe's AstraZeneca and Aventis post strong drug sales, especially in U.S
41. Roche reports sales rose 17% in 1st quarter
42. Novartis sales jumped by 17% in first quarter
43. Roche reports 31% rise in earnings on sale of Genentech unit's shares
44. Roche, Icelandic firm target stroke gene
45. Aventis '99 drug operations were strong
46. BASF nears pact for AHP's Cyanamid
47. GPC to acquire Mitotix, setting stage for an offering in Germany
48. Continued pharmaceuticals growth is expected
49. UBS says quarterly profit surged, declares its big merger a success
50. DuPont Pharmaceuticals to buy research center from Aventis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.